Cargando…
Is lymphopenia different between SARS and COVID‐19 patients?
Lymphopenia is commonly observed in SARS and COVID‐19 patients although the lymphocyte count is not always below 0.8 × 10(9)/L in all the patients. It is suggested that lymphopenia serves as a useful predictor for prognosis in the patients. It is also hypothesized that lymphopenia is related to gluc...
Autores principales: | Yan, Shaomin, Wu, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995142/ https://www.ncbi.nlm.nih.gov/pubmed/33495994 http://dx.doi.org/10.1096/fj.202002512 |
Ejemplares similares
-
Telomeres and COVID‐19
por: Aviv, Abraham
Publicado: (2020) -
The lysosome: A potential juncture between SARS‐CoV‐2 infectivity and Niemann‐Pick disease type C, with therapeutic implications
por: Ballout, Rami A., et al.
Publicado: (2020) -
S100A8 may govern hyper‐inflammation in severe COVID‐19
por: Deguchi, Atsuko, et al.
Publicado: (2021) -
COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
por: Sorokin, Alexander V., et al.
Publicado: (2020) -
Sialylation of host proteins as targetable risk factor for COVID‐19 susceptibility and spreading: A hypothesis
por: Bongiovanni, Antonella, et al.
Publicado: (2021)